# US 2008/0076928 A1 · Novel pharmaceutical salts of 1-benzyl-4-&lsqb; (5,6-dimethoxy-1-indanone)-2-yl&rsqb; methyl piperidine ( Donepezil)

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2008/0076928 A1
- Document ID: US20080076928A1
- Status: Published application
- Kind: A1
- Application number: 11/412,294
- Filed: 2006-04-27
- Published: 2008-03-27
- Earliest claimed: 2004-06-29
- Inventors: Venkatasubramanian Radhakrishnan Tarur; Dhanajay Govind Sathe; Avinash Vankatraman Naidu; Kamiesh Digamber Sawant; Tushar Anil Naik; Umesh Parashram Aher; Sachin Shivali Patil
- Web page: https://patentgrep.com/patent/US20080076928A1

## CPC

- C07D 211/32: by oxygen atoms
- C07D: HETEROCYCLIC COMPOUNDS (macromolecular compounds C08)

## Abstract

New salts of donepezil, and new polymorphic forms of donepezil and its salts, and methods to prepare both the amorphous form and various polymorphic forms of donepezil or its salts.

## Claims

### Claim 1

A donepezil salt selected from the group consisting of: donepezil oxalate, donepezil maleate and donepezil fumarate.

### Claim 2 (depends on 1)

The invention of claim 1, comprising donepezil maleate.

### Claim 3 (depends on 1)

The invention of claim 1, comprising donepezil fumarate.

### Claim 4 (depends on 1)

The invention of claim 1, comprising donepezil oxalate.

### Claim 5 (depends on 1)

A process for making the invention of claim 1, said process comprising:
a. dissolving donepezil base in ethyl acetate to make a donepezil base solution;
b. dissolving a suitable acid in a second solvent to make an organic acid solution;
c. combining said donepezil base solution with said organic acid solution to make a donepezil salt solution; and
d. isolating donepezil salt from said donepezil salt solution.

### Claim 6 (depends on 5)

The process of claim 5, said suitable acid comprising maleic acid.

### Claim 7 (depends on 5)

The process of claim 5, said suitable acid comprising fumaric acid.

### Claim 8 (depends on 5)

The process of claim 5, said isolating performed by adding an anti-solvent to said donepezil salt solution in an amount sufficient to cause said donepezil salt to form a precipitate.

### Claim 9 (depends on 8)

The process of claim 8, wherein the anti-solvent comprises a compound selected from the group consisting of: tetrahydrofuran: diethyl ether; diisopropyl ether; n-hexane; propan-2-ol; acetonitrile; and toluene.

### Claim 10

A process for obtaining a salt of Donepezil of amorphous crystalline structure, the process comprising evaporating a solvent from a solution containing a donepezil salt.

### Claim 11 (depends on 10)

The process as claimed in claim 10 wherein the solvent comprises a lower chain alcohol and wherein said donepezil salt comprises donepezil fumarate.

### Claim 12 (depends on 11)

The process as claimed in claim 11 wherein the solvent comprises a chlorinated hydrocarbon and wherein said donepezil salt is selected from the group consisting of donepezil maleate and donepezil oxalate.

### Claim 13

Donepezil or a pharmaceutically acceptable salt thereof having a powder X-ray diffraction angle (2θ) selected from the group consisting of 9.858±0.4; 11.053±0.2; 11.414±0.2; 13.909±0.2; 14.367±0.4; 17.792±0.4; 20.680±0.2; and 25.712±0.4.

### Claim 14 (depends on 13)

The invention of claim 13, having a powder X-ray diffraction angle (2θ) of 14.367±0.4.

### Claim 15 (depends on 14)

The invention of claim 14, having powder X-ray diffraction angles (2θ) of 14.367±0.4 and 13.909±0.2.

### Claim 16 (depends on 13)

The invention of claim 13, having a powder X-ray diffraction angle of (2θ) of 9.858±0.4.

### Claim 17 (depends on 13)

The invention of claim 13, having a powder X-ray diffraction angle of (2θ) of 17.792±0.4.

### Claim 18 (depends on 13)

The invention of claim 13, having a powder X-ray diffraction angle of (2θ) of 25.712±0.4.

### Claim 19 (depends on 13)

The invention of claim 13, having a powder X-ray diffraction angle of (2θ) of 9.858±0.4, 17.792±0.4 and 25.712±0.4.

### Claim 20 (depends on 13)

The invention of claim 13, having at least three powder X-ray diffraction angles (2θ) selected from the group consisting of 9.858±0.4; 11.053±0.2; 11.414±0.2; 17.792±0.4; 20.680±0.2; and 25.712±0.4.
